Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

Learn how clotting factor therapy, gene therapy, and non-factor treatments are improving hemophilia prognosis and life expectancy.

A gene transfer approach to treating the bleeding disorder hemophilia B remains safe and effective long-term, as scientists ...

Subsequent studies by other investigators confirmed those early results, ultimately leading to the FDA approval of ...

Columnist Jennifer Lynne argues that her health is not defined by her diagnoses, and in fact those terms can often be too limited.

Blood clotting represents one of the body’s most elegant and complex protective mechanisms. This intricate process involves numerous proteins working in precise sequence – often described as a ...

According to a new study in Haemophilia, up to 60% of patients with severe HA have no known family history, making early ...

As a mom to a child withhemophilia, stepping away from sports seemed to be the only way to keep him protected from a life-threatening bleed.

Researchers from the Centenary Institute have uncovered a reason why some people with hemophilia A develop resistance to their critical treatment, paving the way for the development of more effective ...

A gene transfer approach to treating the bleeding disorder hemophilia B remains safe and effective long-term, as scientists from St. Jude Children's ...